toansa
FDA extends Ranbaxy ban
January 27, 2014Manufacturing and Production, Sales and Marketing API, FDA, Ranbaxy, toansa
India-based generic manufacturer Ranbaxy Laboratories has been dealt a further blow as the US regulator has banned more of its …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
